The Truth About Erythema Migrans
Henry M. Feder
Abstract
Henry M. Feder
Abstract
LYME DISEASE in Europe and the United States is caused by different strains of the spirocheteBorrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termederythema chronicum migrans(ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States. In this issue of theArchives, Hulshof and colleagues4from the Netherlands report on the excellent outcome of 44 European patients
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
LYME DISEASE in Europe and the United States is caused by different strains of the spirocheteBorrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termederythema chronicum migrans(ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States. In this issue of theArchives, Hulshof and colleagues4from the Netherlands report on the excellent outcome of 44 European patients
Key concepts: Erythema chronicum migrans, Borrelia burgdorferi, Erythema migrans, Dermatology, Medicine, Lyme disease, Rash, Pathognomonic